Improvement of goiter volume reduction after 0.3 mg recombinant human thyrotropin-stimulated radioiodine therapy in patients with a very large goiter: a double-blinded, randomized trial.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2007-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/JC.2007-0501PMID 17566091
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of a mandatory iodization program on thyroid gland volume based on individuals' age, gender, and preceding severity of dietary iodine deficiency: a prospective, population-based study.

  2007cited by this paper
• Radioiodine therapy in non-toxic multinodular goitre. The possibility of effect-amplification with recombinant human TSH (rhTSH)

  2006cited by this paper
• Transient goiter enlargement after administration of 0.3 mg of recombinant human thyrotropin in patients with benign nontoxic nodular goiter: a randomized, double-blind, crossover trial.

  2006cited by this paper
• Low-dose recombinant human thyrotropin-aided radioiodine treatment of large, multinodular goiters in elderly patients.

  2006cited by this paper
• Stimulation with 0.3-mg recombinant human thyrotropin prior to iodine 131 therapy to improve the size reduction of benign nontoxic nodular goiter: a prospective randomized double-blind trial.

  2006cited by this paper
• Quality of life in patients with benign thyroid disorders. A review.

  2006cited by this paper
• Recombinant human thyrotropin markedly changes the 131I kinetics during 131I therapy of patients with nodular goiter: an evaluation by a randomized double-blinded trial.

  2005cited by this paper
• Recombinant human thyrotropin as adjuvant in the treatment of multinodular goiters with radioiodine.

  2005cited by this paper
• Management of the nontoxic multinodular goiter in Latin America: comparison with North America and Europe, an electronic survey.

  2005cited by this paper
• The effects of recombinant human thyrotropin, in normal subjects and patients with goitre

  2004cited by this paper
• Propylthiouracil before 131I therapy of hyperthyroid diseases: effect on cure rate evaluated by a randomized clinical trial.

  2004cited by this paper
• Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres

  2004cited by this paper
• Long-term effects of radioiodine on thyroid function, size and patient satisfaction in non-toxic diffuse goitre.

  2004cited by this paper
• Differences between endocrine surgeons and endocrinologists in the management of non‐toxic multinodular goitre

  2003cited by this paper
• Management of simple nodular goiter: current status and future perspectives.

  2003cited by this paper
• Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter.

  2003cited by this paper
• Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter.

  2003cited by this paper
• Utility of recombinant human thyrotropin for augmentation of radioiodine uptake and treatment of nontoxic and toxic multinodular goiters.

  2003cited by this paper
• MR imaging of large multinodular goiters: observer agreement on volume versus observer disagreement on dimensions of the involved trachea.

  2002cited by this paper
• Management of the nontoxic multinodular goiter: a North American survey.

  2002cited by this paper
• A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter.

  2001cited by this paper
• Administration of a single low dose of recombinant human thyrotropin significantly enhances thyroid radioiodide uptake in nontoxic nodular goiter.

  2000cited by this paper
• Management of the nontoxic multinodular goitre: A European questionnaire study

  2000cited by this paper
• Determinants of longterm outcome of radioiodine therapy of sporadic non‐toxic goitre

  1999cited by this paper
• The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: effect on thyroid function and size and pulmonary function.

  1999cited by this paper
• Experience in a specialist thyroid surgery unit: a demographic study, surgical complications, and outcome.

  1997cited by this paper
• Large, Compressive Goiters Treated with Radioiodine

  1994cited by this paper
• Radioiodine treatment of multinodular non-toxic goitre.

  1993cited by this paper

• Long-Term Effects of 0.1 mg Recombinant-Human-Thyrotropin-Stimulated Fixed-Dose Radioiodine Therapy in Patients with Recurrent Multinodular Goiter after Surgery

  2024influential citation
• The EANM guideline on radioiodine therapy of benign thyroid disease

  2023influential citation
• A Giant Goiter Challenge

  2023cites this paper
• The Role of Nuclear Medicine in the Clinical Management of Benign Thyroid Disorders, Part 2: Nodular Goiter, Hypothyroidism, and Subacute Thyroiditis

  2021influential citation
• Radioiodine Therapy (RIT) of thyroid autonomy.

  2021cites this paper
• Long Term Follow-Up of Patients with Nontoxic Benign Nodular Goiter Treated with 131Iodine Therapy

  2021cites this paper
• Effect of thyroidectomy in patients with tracheal compression.

  2021cites this paper
• Mechanistic reasoning and the problem of masking

  2021cites this paper
• Recombinant human thyrotropin (rhTSH)-aided radioiodine treatment for non-toxic multinodular goitre.

  2021cites this paper
• Recombinant Human Thyrotropin-Stimulated Radioiodine Therapy in Patients with Multinodular Goiters: A Meta-Analysis of Randomized Controlled Trials

  2020influential citation
• Radioiodine Therapy for Benign Thyroid Disease

  2020cites this paper
• An overview of retrosternal goiter

  2020cites this paper
• Radioiodine-131 therapy (RIT) in benign thyroid diseases: Personalized prescription based on objectives with optional use of pharmacological modulators

  2020cites this paper
• Nontoxic Multinodular Goiter

  2019cites this paper
• Radioiodine Therapy of Benign Thyroid Diseases

  2019cites this paper
• Gathering Evidence of Mechanisms

  2018cites this paper
• Recombinant human thyrotropin stimulation prior to 131I therapy in toxic multinodular goitre with low radioactive iodine uptake.

  2017cites this paper
• La estimulación previa con rhTSH mejora la respuesta al tratamiento con radioyodo en pacientes con bocio multinodular tóxico de baja captación

  2017cites this paper
• Radioiodtherapie bei benignen Schilddrüsenerkrankungen (Version

  2017cites this paper
• Chapter 1 Evaluating evidence of mechanisms in medicine Principles and procedures

  2017cites this paper
• Thyroidectomy Improves Tracheal Anatomy and Airflow in Patients with Nodular Goiter: A Prospective Cohort Study

  2017cites this paper
• Recombinant human thyrotropin stimulation prior to 131I therapy in toxic multinodular goiter with low radioactive iodine uptake

  2017cites this paper
• Single, very low dose (0.03 mg) of recombinant human thyrotropin (rhTSH) effectively increases radioiodine uptake in the I-131 treatment of large nontoxic multinodular goiter.

  2016cites this paper
• Recombinant human thyrotropin stimulated 131I treatment for multinodular goiter

  2016influential citation
• Which Is the Ideal Treatment for Benign Diffuse and Multinodular Non-Toxic Goiters?

  2016cites this paper
• THYROIDMANAGER . ORG CHAPTER 17 – MULTINODULAR GOITER

  2016influential citation
• [Radioiodine therapy for benign thyroid diseases (version 5). German Guideline].

  2016cites this paper
• Thyroid Disease in the Elderly

  2016cites this paper
• Radioiodtherapie bei benignen Schilddrüsenerkrankungen (Version 5)*

  2016cites this paper
• Management of the Thyroid Nodule: A Comparison of Published International Guidelines

  2016cites this paper
• Chapter 90 – Multinodular Goiter

  2016cites this paper
• Когнитивные расстройства в послеоперационном периоде в хирургии щитовидной железы

  2015cites this paper
• Recombinant human thyrotropin before 131I therapy in patients with nodular goitre: a meta‐analysis of randomized controlled trials

  2015cites this paper
• Long-Term Efficacy of Modified-Release Recombinant Human Thyrotropin Augmented Radioiodine Therapy for Benign Multinodular Goiter: Results from a Multicenter, International, Randomized, Placebo-Controlled, Dose-Selection Study

  2014cites this paper
• Long-term outcome after radioiodine therapy with adjuvant rhTSH treatment: comparison between patients with non-toxic and pre-toxic large multinodular goitre

  2014cites this paper
• Recombinant human TSH and radioactive iodine therapy in the management of benign multinodular goiter.

  2014cites this paper
• Substantial interobserver variation of thyroid volume and function by visual evaluation of thyroid (99m)Tc scintigraphy.

  2014cites this paper
• The role of radioiodine therapy in benign nodular goitre.

  2014cites this paper
• Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for non‐toxic multinodular goitre

  2013cites this paper
• Approach to and treatment of goiters.

  2012cites this paper
• Prestimulation with recombinant human thyrotropin (rhTSH) improves the long-term outcome of radioiodine therapy for multinodular nontoxic goiter.

  2012cites this paper
• Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome.

  2012cites this paper
• Radioiodine Therapy of Hyperthyroidism (Toxic Goiter, Hyperfunctioning Nodule) and Non-Toxic Goiter: Procedures and Guidelines

  2012cites this paper
• Inability of recombinant human thyrotropin to predict the evolution from subclinical hypothyroidism to overt disease. A pilot study

  2011cites this paper
• The American Thyroid Association/American Association of Clinical Endocrinologists Guidelines for Hyperthyroidism and Other Causes of Thyrotoxicosis: A European Perspective

  2011cites this paper
• Serum thyroxine and age--rather than thyroid volume and serum TSH--are determinants of the thyroid radioiodine uptake in patients with nodular goiter.

  2011cites this paper
• A randomized trial evaluating a block‐replacement regimen during radioiodine therapy

  2011cites this paper
• Non-surgical approach to the benign nodular goiter: new opportunities by recombinant human TSH-stimulated 131I-therapy

  2011cites this paper
• Poorly differentiated thyroid carcinoma in a 9-year-old boy: case report

  2011cites this paper
• Nodular diseases in the thyroid.

  2011cites this paper
• Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled study.

  2011cites this paper
• Modified-Release Recombinant Human TSH (MRrhTSH) Augments the Effect of 131I Therapy in Benign Multinodular Goiter: Results from a Multicenter International, Randomized, Placebo-Controlled Study

  2011cites this paper
• Endocrine Society of India management guidelines for patients with thyroid nodules: A position statement

  2011cites this paper
• Serum thyroxine and age — rather than thyroid volume and serum TSH — are determinants of the thyroid radioiodine uptake in patients with nodular goiter

  2011cites this paper
• Radioiodine therapy of benign non-toxic goitre. Potential role of recombinant human TSH.

  2011cites this paper
• Radioiodine 131I Treatment for Large Nodular Goiter: Recombinant Human Thyrotropin Allows the Reduction of Radioiodine 131I Activity to Be Administered in Patients with Low Uptake

  2011cites this paper
• Thyroid nodule guidelines: agreement, disagreement and need for future research

  2011cites this paper
• Role of recombinant human TSH in the management of large euthyroid multinodular goitre: a new therapeutic option? Pros and cons.

  2010cites this paper
• Recombinant human thyrotropin-stimulated radioiodine therapy of nodular goiter allows major reduction of the radiation burden with retained efficacy.

  2010cites this paper
• Approach to management of the patient with primary or secondary intrathoracic goiter.

  2010cites this paper
• Stability of Recombinant Human Thyrotropin Potency Based on Bioassay in FRTL-5 Cells

  2010cites this paper
• Evidence-based mechanistic reasoning

  2010cites this paper
• Radioiodine plus recombinant human thyrotropin do not cause acute airway compression and are effective in reducing multinodular goiter.

  2010cites this paper
• Diagnóstico y tratamiento del nódulo tiroideo. Posición de la Sociedad Mexicana de Nutrición y Endocrinología, A.C.

  2010cites this paper
• Radioiodine Therapy After Pretreatment With Recombinant Thyroid-stimulating Hormone (tsh) in Toxic Multinodular Goiter With Low Radioactive Iodine Uptake

  2010cites this paper
• CHAPTER 90 – Disorders of the Thyroid

  2010cites this paper
• Dose‐dependent acute effects of recombinant human TSH (rhTSH) on thyroid size and function: comparison of 0·1, 0·3 and 0·9 mg of rhTSH

  2010cites this paper
• Time to reconsider nonsurgical therapy of benign non-toxic multinodular goitre: focus on recombinant human TSH augmented radioiodine therapy.

  2009influential citation
• Radioiodine therapy for thyroid volume reduction of large goitres

  2009cites this paper
• Optimizing 131 I Uptake After rhTSH Stimulation in Patients with Nontoxic Multinodular Goiter : Evidence from a Prospective , Randomized , Double-Blind Study

  2009cites this paper
• Administração prévia do TSH humano recombinante, em diferentes doses, no tratamento do bócio multinodular com iodo radioativo: um estudo randomizado, duplo cego, controlado com placebo

  2009cites this paper
• Optimizing 131I Uptake After rhTSH Stimulation in Patients with Nontoxic Multinodular Goiter: Evidence from a Prospective, Randomized, Double-Blind Study

  2009cites this paper
• Recombinant human TSH increases the efficacy of a fixed activity of radioiodine for treatment of multinodular goitre

  2009cites this paper
• A 30-year perspective on radioiodine therapy of benign nontoxic multinodular goiter*

  2009cites this paper
• Long-term outcome of low-activity radioiodine administration preceded by adjuvant recombinant human TSH pretreatment in elderly subjects with multinodular goiter

  2009cites this paper
• Recombinant human thyrotropin-stimulated radioiodine therapy of large nodular goiters facilitates tracheal decompression and improves inspiration.

  2008cites this paper
• Recombinant human thyrotropin in the management of thyroid disorders

  2008cites this paper
• Tratamiento del bocio multinodular con radioyodo

  2008cites this paper
• Der Schilddrüsenknoten – Differentialdiagnostik und Therapiekonzepte

  2008cites this paper
• An outline concerning the potential use of recombinant human thyrotropin for improving radioiodine therapy of multinodular goiter

  2008cites this paper
• Thiamazole as an adjuvant to radioiodine for volume reduction of multinodular goiter

  2008cites this paper
• Evaluation of various doses of recombinant human thyrotropin in patients with multinodular goiters.

  2008cites this paper
• Recombinant human thyrotropin in the management of thyroid disorders.

  2008cites this paper
• Radioiodine therapy for multinodular goiter.

  2008cites this paper
• Review on the Occasion of a Decade of Recombinant Human TSH: Prospects and Novel Uses

  2008cites this paper
• Utilisation de la thyreostimuline humaine recombinante dans la préparation au traitement par iode-131 des pathologies thyroïdiennes

  2008cites this paper
• Current Readings in Nuclear Medicine

  1994cites this paper
• Follicular thyroid cancer Papillary thyroid cancer Medullary thyroid cancer Anaplastic Cancer Lymphoma Other cancer / Metastasis

  year unknowncites this paper
• Guidelines for Management of Thyroid Nodules in Adults : Towards a Consensus

  year unknowncites this paper